Patient Information
Melasma Treatment ProtocolPigmentation from sun exposure, hormones and predisposition
The key treatment steps for melasma — with consistent sun protection as the foundation of every further therapy.
In short: Melasma are brownish patches on the face caused mainly by sunlight, hormones (e.g. pregnancy, the contraceptive pill) and sometimes a genetic predisposition. Treatment requires patience, as the patches usually fade only slowly. The most important building block is consistent sun protection — without it, no other therapy works in the long term.
What is melasma?
Melasma are brownish patches on the face caused mainly by sunlight, hormones (for example pregnancy or the contraceptive pill) and sometimes a genetic predisposition. Treatment requires patience, as the patches usually fade only slowly.
The most important building block of treatment is consistent sun protection — without it, no other therapy works in the long term.
Treatment steps
Melasma cannot be cured, but it can be well controlled with consistent sun protection, individualised cream therapy and patience.
Important to know
- Treating melasma usually takes several months.
- Even after successful treatment, the patches can return, especially with sun exposure or hormonal changes — which is why lasting sun protection is essential.
- All creams, tablets and laser treatments should only be started after medical consultation.
Sources
- Clinical basis of this treatment protocol: treatment description provided by Dr. med. Paul Georg.
- Sarkar R, Desai SR, Sinha S, et al., Delphi consensus on melasma management by international experts and Pigmentary Disorders Society, Journal of the European Academy of Dermatology and Venereology (2026).
- Kwon SH, Na JI, Choi JY, Park KC, Melasma: Updates and perspectives, Experimental Dermatology (2019).
- Yao H, Shen S, Gao X, et al., Definition of refractory melasma and its treatment: a review, Lasers in Medical Science (2024).
- Gan C, Rodrigues M., An Update on New and Existing Treatments for the Management of Melasma, American Journal of Clinical Dermatology (2024).
- Morgado-Carrasco D, Piquero-Casals J, Granger C, Trullàs C, Passeron T, Melasma: The need for tailored photoprotection to improve clinical outcomes, Photodermatology, Photoimmunology & Photomedicine (2022).
- Kundu RV, Riley JM, et al., Managing Facial Hyperpigmentation, JAMA Dermatology (2023).
- Ghasemiyeh P, Haghighi NF, Dastgheib L, Ranjbar S, Mohammadi-Samani S, Safety and efficacy of niosomal and conventional tranexamic acid/niacinamide vs. hydroquinone creams in melasma: a randomized, double-blind, case-controlled clinical trial, Scientific Reports (2025).
- Four further sources named by the user (on trichloroacetic-acid peeling and erbium-laser combination studies) could not be confirmed as findable during this research and are therefore not listed here.